Literature DB >> 21108606

Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.

Jun Dou1, Cuilian Jiang, Jing Wang, Xian Zhang, Fengshu Zhao, Weihua Hu, Xiangfeng He, Xiaoli Li, Dandan Zou, Ning Gu.   

Abstract

CSCs (cancer stem cells) are a small subset of cells within a tumour that possesses the characteristics of stem cells and are considered to be responsible for resistance to chemoradiation. Identification of CSCs through stem cell characteristics might have relevant clinical implications. In this study, SP (side population ) cells were sorted from a human ovarian cancer cell line by FACS to determine whether cancer stem cell-like SP cells were present. A very small fraction of SP cells (2.6%) was detected in A2780 cells. SP cells possessed the following characteristics: highly proliferative activity, marked ability for self-renewal in soft agar and culture medium, high expression of ABCG2, drug resistance to vinblastine in vitro, and strong tumourigenic potential in Balb/c nude mice. It is concluded that there exists in the A2780 cell line a small number of SP cells with high expression of ABCG2. The cells have the characteristics of cancer stem-like cells, and identification and cloning of such human SP cells can help in improving therapeutic approaches to ovarian cancer in patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21108606     DOI: 10.1042/CBI20100347

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  23 in total

1.  Dynamic ABCG2 expression in human embryonic stem cells provides the basis for stress response.

Authors:  Zsuzsa Erdei; Balázs Sarkadi; Anna Brózik; Kornélia Szebényi; György Várady; Veronika Makó; Adrienn Péntek; Tamás I Orbán; Ágota Apáti
Journal:  Eur Biophys J       Date:  2012-08-01       Impact factor: 1.733

Review 2.  Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.

Authors:  Xiaoxiang Chen; Jing Zhang; Zhihong Zhang; Hongxia Li; Wenjun Cheng; Jinsong Liu
Journal:  Hum Pathol       Date:  2013-07-11       Impact factor: 3.466

3.  Targeting cancer stem cells: a new therapy to cure cancer patients.

Authors:  Yapeng Hu; Liwu Fu
Journal:  Am J Cancer Res       Date:  2012-04-28       Impact factor: 6.166

Review 4.  Ovarian cancer stem cells: are they real and why are they important?

Authors:  Monjri M Shah; Charles N Landen
Journal:  Gynecol Oncol       Date:  2013-12-07       Impact factor: 5.482

5.  Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.

Authors:  Sarama Saha; Seema Parte; Partha Roy; Sham S Kakar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Authors:  Peyman Ranji; Tayyebali Salmani Kesejini; Sara Saeedikhoo; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2016-08-26

7.  Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.

Authors:  Rachel Eyre; Ian Harvey; Katherine Stemke-Hale; Thomas W J Lennard; Alison Tyson-Capper; Annette P Meeson
Journal:  Tumour Biol       Date:  2014-07-04

8.  Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells.

Authors:  Jun Dou; Yaoyao Ni; Xiangfeng He; Di Wu; Miao Li; Songyan Wu; Rong Zhang; Mei Guo; Fengsu Zhao
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

9.  Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis.

Authors:  Obeid M Malekshah; Siddik Sarkar; Alireza Nomani; Niket Patel; Parisa Javidian; Michael Goedken; Marianne Polunas; Pedro Louro; Arash Hatefi
Journal:  J Control Release       Date:  2019-09-06       Impact factor: 9.776

10.  Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.

Authors:  Junsong Chen; Jing Wang; Dengyu Chen; Jie Yang; Cuiping Yang; Yunxia Zhang; Hongyi Zhang; Jun Dou
Journal:  BMC Cell Biol       Date:  2013-01-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.